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Abstract
Background: Acute kidney injury (AKI) after cardiac surgery is associated with increased morbidity and mortality.
The long-term association between AKI and end-stage renal disease (ESRD) in an Asian population is unknown.
Given the high prevalence of diabetes and a younger age of presentation for cardiac surgery, it is important to
track this progression of kidney disease. Therefore, we studied the long-term risk of ESRD and mortality in our Asian
patients who developed AKI after cardiac surgery.
Methods: With ethics approval, we prospectively recruited 3008 patients who underwent cardiac surgery in
Singapore between 2008 and 2012, and followed them up till 2014. ESRD and mortality information were obtained
from the Singapore Renal Registry and Singapore Registry of Births and Deaths respectively. AKI was defined using
the Acute Kidney Injury Network (AKIN) criteria, and ESRD was defined as stage 5 chronic kidney disease requiring
renal replacement therapy. The Cox proportional hazards regression model was used to analyze associations
between AKI and the primary outcome of ESRD and the secondary outcome of death.
Results: The AKI incidence was 29.1%. During a mean follow-up of 4.4 ± 2.8 years, 0.9% developed ESRD. The hazard
ratio (HR) for developing ESRD was 4.7 (95% C.I. = 1.736–12.603, p = 0.002) for AKIN stage 1 patients, and 5.8 (95%
C.I. = 1.769–18.732, p = 0.004) for AKIN stage 2 and 3 patients; while the HR for mortality was 1.7 (95% C.I. = 1.165–2.571,
p = 0.007) for AKIN stage 1 patients, and 2.5 (95% C.I. = 1.438–4.229, p < 0.001) for AKIN stage 2 and 3 patients.
Conclusions: AKI is associated with ESRD and mortality after cardiac surgery in our Asian population. The trajectory
from AKI to ESRD is rapid within 5 years of cardiac surgery. A concerted periodic follow-up assessment is advocated for
AKI patients post-cardiac surgery.
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Background
Acute kidney injury (AKI), a common complication after
cardiac surgery, occurs in one out of three patients [1–3].
While it has been previously thought that AKI resolves
with no long-term sequelae, it is now increasingly recog-
nized that it is associated with development of chronic
kidney disease (CKD), end-stage renal disease (ESRD) and
increases long-term mortality [4–9].
Amongst cardiac surgical patients, Rydén et al. dem-
onstrated that a small increase in serum creatinine was
associated with an almost 3-fold increase in the long-
term risk of developing ESRD [10]; while Lo LJ et al.
found that amongst all hospitalized patients, dialysis-
requiring AKI patients had a 28-fold increased risk of
developing stage 4 chronic kidney disease or ESRD,
compared with patients who did not develop AKI [11].
This association between an episode of AKI after car-
diac surgery and the risk of subsequent development of
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ESRD in an Asian population is unknown. It is therefore
important to track the trajectory of progression of kid-
ney disease following an acute episode of AKI in our
Asian population, especially as the health and financial
burden of ESRD is likely increased with our high preva-
lence of diabetes and younger age of presentation for
cardiac surgery. Furthermore, given the extremely high
local burden of ESRD [12], we embarked on this study
to determine the long-term risk of ESRD and mortality
in Singapore post-AKI after cardiac surgery.
Methods
Study population
With Institutional Review Board approval (Domain Spe-
cific Review Board 2015/00398) and written informed
consent, we prospectively followed up all adult patients
above 21 years old from August 2008 till 30 December
2014. These patients underwent cardiac surgery at two
main heart centres in Singapore between August 2008
and July 2012. Perioperative safety and outcomes data
were prospectively collected and entered into a cardiac
anaesthesia database. The exclusion criteria for analysis
were: (1) non-citizens and non-permanent residents; (2)
patients on existing dialysis; (3) pre-existing ESRD pa-
tients; and (4) inpatient mortality cases.
Definition of eGFR, normal serum creatinine, AKI, ESRD
The estimated glomerular filtration rate (eGFR) was cal-
culated using the Chronic Kidney Disease Epidemiology
Collaboration equation [13].
Normal serum creatinine was defined as 60 to
105 μmol/L for males and 40 to 75 μmol/L for females.
AKI was defined using the Acute Kidney Injury Net-
work (AKIN) criteria - stage 1: ≥26.4 μmol/L or ≥50–
100%; stage 2: 100–200%; stage 3: ≥354 μmol/L with an
acute increase of ≥44 μmol/L or ≥200% increase between
pre- and post-operative serum creatinine. The pre-
operative serum creatinine was defined as the creatinine
value recorded within 1 week before surgery unless there
was a material change in the patient’s condition; while
the peak post-operative serum creatinine was the highest
creatinine within 48 h after surgery [6].
ESRD was defined as stage 5 CKD (where the glom-
erular filtration rate was <15 ml/min/1.73 m2) requiring
renal replacement therapy [14].
Outcome data
All Singaporean citizens and permanent residents have a
unique personal identification number. Identification of
ESRD patients amongst the cohort was accomplished
through record linkage of cohort files with the Singapore
Renal Registry of the National Registry of Diseases Of-
fice. This is a nationwide database of patients who have
received renal replacement therapy and includes the date
of entry into a renal replacement program and/or renal
transplantation. The data capture for ESRD is estimated
to be 95% complete [15]. This study used the date of
first renal replacement therapy to define the start of
ESRD as reported to the Registry.
Survival records were captured through matching of
patient’s identification number with the Singapore
Registry of Births and Deaths.
Statistical analysis
Population demographics, medical history, pre-operative
risk assessment, intra-operative variables and post-
operative outcomes were analysed descriptively. Univari-
ate analyses were done using 2-tailed unpaired T-test for
continuous variables and Chi-square for categorical vari-
ables to identify the risk factors for ESRD. Patients con-
tributed person-time in days from the time of surgery
and were censored at the time of death from any cause,
start of renal replacement therapy or end of the follow
up period (December 30, 2014), whichever is earlier.
The Cox proportional hazards regression model was
used to analyse associations between AKI and the pri-
mary outcome of ESRD and the secondary outcome of
death. The statistical significance of variables was taken
as p < 0.05. All statistical analyses were performed using
IBM SPSS version 22.0 (Armonk, NY, USA).
Results
The patient characteristics are shown in Table 1. A
total of 3008 patients were recruited during the study
period. The total number of patients who met the
inclusion and exclusion criteria was 2666. The mean
age was 59.3 ± 10.5 years of which 523 were women.
Overall incidence of AKI and ESRD
The overall incidence of post-operative AKI in our co-
hort was 29.1% (n = 777 out of 2666). Of these AKI pa-
tients, 78% (n = 608), 17.5% (n = 134), and 4.5% (n = 35)
developed AKI of AKIN stage 1, 2 and 3 respectively.
72.7% (n = 1938 out of 2666) of patients had normal
pre-operative serum creatinine. The mean pre-operative
eGFR for the cohort was 81.0 ± 21.6 mL/min/1.73 m2.
Patients who developed AKI were males, older, had
diabetes mellitus and hypertension, and pre-operative
anaemia, poorer pre-operative renal function and lower
nadir haematocrit during bypass. A total of 59 (2.2%)
patients had a new need for dialysis in the post-
operative period (Table 1).
During a mean follow-up of 4.4 ± 2.8 years, a total of
24 patients (0.9%) developed ESRD, including 12 (out of
608, 2.0%) with AKIN stage 1 AKI, 5 (out of 134, 3.7%)
with AKIN stage 2 AKI, and 1 (out of 35, 2.9%) with
AKIN stage 3 AKI. 6 patients (out of 1889, 0.3%) with-
out AKI developed ESRD within the follow-up period.
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Age (years) 59.3 ± 10.5 58.0 ± 10.5 62.3 ± 9.6 62.4 ± 10.6 <0.001
Gender: male 2143 (80.4) 1534 (81.2) 486 (79.9) 123 (72.8) 0.029
Ethnicity Chinese 1912 (71.7) 1390 (73.6) 414 (68.1) 108 (63.9) <0.001
Malay 425 (15.9) 271 (14.3) 126 (20.7) 28 (16.6)
Indian 329 (12.3) 228 (12.1) 68 (11.2) 33 (19.5)
Body mass index (kg/m2) 25.0 ± 4.1 24.9 ± 4.0 25.4 ± 4.3 24.9 ± 4.7 0.032
Diabetes mellitus 1205 (45.2) 793 (42.0) 294 (48.4) 118 (69.8) <0.001
Hypertension 1998 (74.9) 1348 (71.4) 503 (82.7) 147 (87) <0.001
Myocardial infarction 1559 (58.5) 1072 (56.7) 379 (62.3) 108 (63.9) 0.017
Congestive cardiac failure 435 (16.3) 260 (13.8) 130 (21.4) 45 (26.6) <0.001
Renal impairment 225 (8.4) 90 (4.8) 99 (16.3) 36 (21.3) <0.001
Beta-blocker 1998 (74.9) 1377 (73.1) 482 (79.3) 139 (82.2) 0.001
ACE-inhibitor 1300 (48.8) 905 (48.0) 306 (50.3) 89 (52.7) 0.365
Calcium channel blocker 521 (19.5) 331 (17.6) 144 (23.7) 46 (27.2) <0.001
Statin 2159 (81.0) 1526 (81.0) 494 (81.7) 139 (82.2) 0.881
Diuretic 480 (18.0) 276 (14.6) 149 (24.5) 55 (32.5) <0.001
Ejection fraction (<30%) 185 (6.9) 110 (5.9) 58 (9.6) 17 (10.2) 0.002
Pre-operative creatinine (μmol/L) 91.0 ± 42.7 85.7 ± 34.6 103.5 ± 51.5 98.7 ± 35.5 <0.001
Pre-operative eGFR (ml/min/1.73 m2) 81.0 ± 21.6 84.8 ± 19.3 71.9 ± 23.9 71.7 ± 23.9 <0.001
Pre-operative haemoglobin (g/dL) 13.5 ± 1.7 13.8 ± 1.6 13.1 ± 1.8 12.7 ± 1.8 <0.001
EuroSCORE logistic 3.6 ± 4.6 3.1 ± 3.7 4.8 ± 6.0 4.9 ± 6.2 <0.001
Surgical variables
Coronary artery bypass graft surgery 2191 (82.2) 1546 (82.2) 506 (83.4) 139 (82.2) 0.802
Valvular surgery 622 (23.3) 433 (22.9) 148 (24.3) 41 (24.3) 0.733
Cardiopulmonary bypass 2578 (96.7) 1820 (96.3) 595 (97.9) 163 (96.4) 0.188
IABP 249 (9.3) 130 (6.9) 89 (14.7) 30 (17.9) <0.001
Cardiopulmonary bypass time (min) 113.5 ± 49.0 107.0 ± 43.4 125.7 ± 56.2 137.3 ± 64.7 <0.001
Aortic cross clamp time (min) 67.2 ± 36.4 63.5 ± 32.8 74.1 ± 42.5 79.5 ± 46.0 <0.001
Inotrope use 1652 (62.0) 1120 (59.9) 409 (67.7) 123 (72.8) <0.001
Haemodilution
Prebypass haematocrit (%) 37.8 ± 4.9 38.3 ± 4.6 36.9 ± 5.3 35.8 ± 4.8 <0.001
Lowest haematocrit during bypass (%) 24.4 ± 3.9 24.9 ± 3.9 23.4 ± 3.7 22.3 ± 3.8 <0.001
RBC transfusion 746 (28.0) 426 (22.6) 238 (39.1) 82 (48.5) <0.001
Intensive care unit variables
Inotrope use 1228 (46.1) 780 (41.3) 336 (55.4) 112 (66.3) <0.001
New need for dialysis 59 (2.2) 12 (0.6) 21 (3.5) 26 (15.4) <0.001
Lowest haemoglobin in 1st 24 h (g/dL) 9.7 ± 1.6 9.9 ± 1.5 9.2 ± 1.4 8.8 ± 1.4 <0.001
RBC transfusion 1010 (37.9) 608 (32.2) 303 (49.9) 99 (58.6) <0.001
Total length of hospitalization (days) 11.0 ± 10.6 9.2 ± 5.6 13.2 ± 9.6 22.0 ± 30.2 <0.001
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Overall, patients who developed AKI had a 7.4 times
(95% Confidence Interval [C.I.] 2.943–18.822) significant
higher risk of developing ESRD (p < 0.001), compared
with patients who did not develop AKI.
The mean age of patients at the diagnosis of ESRD
was 57.3 ± 9.4 years. 87.5% of the ESRD patients were
males. Patients who developed ESRD had a poorer pre-
operative renal function, lower pre-operative haemoglo-
bin and lower nadir haematocrit during bypass, than
those who did not develop ESRD (Table 2).
The incidence of ESRD increased with advancing
AKIN stage (Fig. 1). Compared with the non-AKI
patients, the risk of developing ESRD was 6 and 11 times
higher for patients who developed AKI of AKIN stage 1,
and stage 2 and 3 respectively (p < 0.001, p < 0.001)
(Table 2). After multivariate Cox regression analysis, the
hazard ratio (HR) for developing ESRD was 4.7 (p = 0.002)
for AKIN stage 1 AKI patients, and 5.8 (p = 0.004) for
AKIN stage 2 and 3 AKI patients. Other independent risk
factors in the multivariate analysis include diabetes mellitus
(HR = 20.607, p = 0.003) and lowest haematocrit during
bypass (HR = 0.900, p = 0.032) (Table 3).
All-cause 5-year mortality
During the follow up period, 95% (n = 2538 out of
2666) of patients were alive. The 5-year mortality was
4.8% (n = 128 out of 2666).
The mortality amongst the AKI patients was significantly
higher than non-AKI patients (7.7 vs 3.6%, p < 0.001). 6.7%
of patients with AKI of AKIN stage 1 (n = 41 out of 608)
died within 5 years of surgery, whereas 10.4 and 14.0% of
patients with AKI of AKIN stage 2 (n = 14 out of 134) and
3 (n = 5 out of 35) died within 5 years of surgery
respectively (Table 1).
There was a significant dose-dependent relationship
between the severity of AKI and mortality (p < 0.001)
(Fig. 2). The risk of mortality was 2 and 3 times
significantly higher for patients who developed AKI of
AKIN stage 1, and stage 2 and 3 respectively (p = 0.002,
p= 0.012) (Table 2). The HR for mortality was 1.7 (p= 0.007)
for AKIN stage 1 AKI patients, and 2.5 (p < 0.001) for AKIN
stage 2 and 3 AKI patients (Table 3).
Patients who developed ESRD had a 5.4 times (95%
C.I. = 2.650–11.059) significant higher risk of developing
all-cause 5-year mortality compared to patients who did
not develop ESRD (25.0 vs 4.6%, p = 0.001).
Relationship between eGFR, AKI and ESRD
There is an inverse relationship between eGFR and
ESRD. 88.9% of patients who developed ESRD have
eGFR <60 ml/min/1.73 m2 as compared to 5.6% of
patients with normal eGFR (≥90 ml/min/1.73 m2) and 5.6%
with eGFR between 60 and <90 ml/min/1.73 m2 (p < 0.001).
2.3% (18 out of 777) of patients with AKI developed
ESRD as compared to 0.3% (6 out of 1889) of patients
who did not have AKI but developed ESRD (p < 0.001).
Discussion
AKI is a serious complication with adverse long-term
outcomes. Hitherto, AKI was believed to be self-limiting
[8] but within a 4.4 ± 2.8 years follow-up period, 0.9%
patients locally who underwent cardiac surgery
developed ESRD.
There is a dose-dependent relationship between AKI
and the risk of ESRD. Patients who develoepd ESRD also
have a higher 5-fold mortality after cardiac surgery.
Association of AKI and ESRD
Several epidemiological studies have reported an associ-
ation between AKI and ESRD [16, 17]. In a cohort of
patients who underwent coronary angiography and de-
veloped AKI, the risk of ESRD was more than 4-fold
higher in patients with AKIN stage 1 and almost 12-fold
higher in patients with AKIN stage 2–3 compared to
patients without AKI; and the incidence of ESRD was
0.6% for that study population [16]. In another cohort of
patients who underwent CABG during a 9-year period,
0.4% of the cohort developed ESRD during a mean
follow-up of 4.3 ± 2.4 years [17]. In contrast, during a
mean follow-up of 4.4 ± 2.8 years in our population, a
total of 24 patients (0.9%) developed ESRD, which is
twice as high.
It was previously thought that there is no long-term
sequelae of an episode of AKI with expectant recovery
of renal function. However, recent evidence from
multiple observational studies demonstrated a strong re-
producible association between AKI, subsequent CKD
and ESRD [8, 9, 11, 16]. In some cases, this decline in
renal function after AKI follows a rapid trajectory with
the patient developing accelerated ESRD requiring long-
term renal replacement therapy [17, 18]. We have previ-
ously reported that up to 10% of patients who developed
AKI in the post-operative period after cardiac surgery
Table 1 Univariate analysis of perioperative factors and acute kidney injury for the whole cohort (Continued)
Outcomes
End-stage renal disease 24 (0.9) 6 (0.3) 12 (2.0) 6 (3.6) <0.001
5-year mortality 128 (4.8) 68 (3.6) 41 (6.7) 19 (11.2) <0.001
Data represent number (percent) or mean ± standard deviation
AKI Acute Kidney Injury, AKIN Acute Kidney Injury Network, EuroSCORE European System for Cardiac Operative Risk Evaluation, eGFR estimated glomerular filtration
rate, IABP intra-aortic balloon pump, RBC red blood cell
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have elevated serum creatinine at the point of hospital
discharge [19]. It is clear that some of these patients
develop accelerated ESRD within 5 years as shown in
this study.
AKI is directly associated with the progression of CKD
but it is also postulated that it directly causes CKD [20].
Our study confirmed a dose-dependent relationship be-
tween the increased severity of AKI and increased inci-
dence of ESRD. Other studies have shown that multiple
episodes of AKI predict the development of CKD [21];
and CKD has also been reported in children who had
AKI but had no other risk factors such as hypertension,
diabetes or cardiovascular disease [22]. The evidence for
primary pathogenic links between AKI and CKD
remains to be elucidated, but there is some suggestion
that in acute tubular necrosis there is rapid progression
to ESRD even in patients without pre-existing CKD [20].
These findings suggest that an episode of AKI is par-
ticularly detrimental in a cohort of cardiac surgical
patients who have pre-existing risk factors for CKD. An
episode of AKI in itself can cause CKD as well as worsen
pre-existing CKD. Animal studies have outlined a num-
ber of causal pathways in the progression of renal
dysfunction following AKI [23]. These include maladap-
tive repair, disordered regeneration or both [23]. How-
ever, relatively little is known about the long-term
course of AKI in the setting of cardiac surgery with its
attendant ischemic injuries and inflammation and these
need to be addressed.
Risk factors of AKI and ESRD
The patients who developed ESRD after AKI are mainly
males with an average age of 57.3 ± 9.4 years. This is
relatively young as compared to the age of initiation of
dialysis in other populations, such as that in the United
States where the average age of patients starting on
Table 2 Univariate analysis of perioperative factors and end-stage







Age (years) 57.3 ± 9.4 59.3 ± 10.5 0.604
Gender: male 21 (87.5) 2122 (80.3) 0.345
Ethnicity Chinese 14 (58.3) 1898 (71.8) 0.304
Malay 5 (20.8) 420 (15.9)
Indian 5 (20.8) 324 (12.3)
Body mass index (kg/m2) 25.2 ± 5.1 25.0 ± 4.1 0.839
Diabetes mellitus 23 (95.8) 1182 (44.7) <0.001
Hypertension 22 (91.7) 1976 (74.8) 0.058
Myocardial infarction 18 (75.0) 1541 (58.3) 0.099
Congestive cardiac failure 8 (33.3) 427 (16.2) 0.045
Renal impairment 15 (62.5) 210 (7.9) <0.001
Beta-blocker 21 (87.5) 1977 (75.0) 0.158
ACE-inhibitor 12 (50) 1288 (48.8) 0.910
Calcium channel blocker 10 (41.7) 511 (19.4) 0.016
Statin 24 (100.0) 2135 (81.1) 0.014
Diuretic 8 (33.3) 472 (17.9) 0.061
Ejection fraction (<30%) 22 (91.7) 2440 (93.0) 0.683
Pre-operative creatinine (μmol/L) 235 ± 127 89 ± 36 <0.001
Pre-operative eGFR (ml/min/1.73 m2) 36.3 ± 25.1 81.4 ± 21.1 <0.001
Pre-operative haemoglobin (g/dL) 11.2 ± 1.7 13.6 ± 1.7 <0.001
EuroSCORE logistic 6.9 ± 9.0 3.5 ± 4.5 0.086
Surgical variables
IABP 4 (16.7) 245 (9.3) 0.276
Cardiopulmonary bypass time (min) 103 ± 43 113 ± 49 0.325
Aortic cross clamp time (min) 61 ± 25 67 ± 37 0.424
Inotrope use 21 (87.5) 1631 (62.3) 0.011
Hemodilution
Prebypass haematocrit (%) 31.5 ± 4.9 37.9 ± 4.8 <0.001
Lowest hematocrit during bypass (%) 21.5 ± 3.1 24.4 ± 4.0 <0.001
RBC transfusion 13 (54.2) 733 (27.7) 0.004
Intensive care variables
Inotrope use 13 (54.2) 1215 (46.0) 0.426
New need for dialysis 5 (20.8) 54 (2.0) <0.001
Lowest haemoglobin in 1st 24 h (g/dL) 8.4 ± 1.4 9.7 ± 1.6 <0.001
RBC transfusion 15 (62.5) 995 (37.7) 0.013
Total length of hospitalization (days) 14.7 ± 10.5 10.9 ± 10.6 0.083
Outcomes
Acute kidney injury 18 (75.0) 759 (28.7) <0.001
5-year mortality 6 (25.0) 122 (4.6) 0.001
Data represent number (percent) or mean ± standard deviation
ESRD end-stage renal disease, EuroSCORE European System for Cardiac
Operative Risk Evaluation, eGFR estimated glomerular filtration rate, IABP
intra-aortic balloon pump, RBC red blood cell
Fig. 1 Time to end-stage renal disease for the whole cohort
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dialysis is 64.7 ± 14.5 years [24]. This also reflects the
overall younger age of presentation of heart disease in
the Asian population, but the early age of presentation
of ESRD is particularly alarming given the long-term
morbidity and health burden of this chronic disease.
Diabetes mellitus is especially prevalent in the Asian
population and diabetics who developed AKI are par-
ticularly at risk of developing ESRD. Numerous studies
have shown that South Asians have decreased sensitivity
to insulin when compared with other ethnic groups
which may be related to increased levels of truncal fat
and dysfunctional adipose tissue resulting in a blunted
response to insulin [25]. It is well known that diabetes
mellitus is the leading cause of ESRD worldwide [26]
and the common consensus is an expected, linear, pro-
gressive and time-dependent decline of CKD to ESRD in
the diabetic patient [17, 18]. Perhaps less known is that
after an episode of AKI, the trajectory of accelerated
ESRD is rapid, and we showed that in our population
the rate of decline is as short as 5 years following cardiac
surgery. This corroborates with recent publications [17, 18]
and has tremendous implications on ESRD care planning
as it affects mainly males of a relatively younger age group
compared to their Western counterpart.
Equally important is the modification of risk factors
that will retard the risk of AKI and subsequent ESRD.
Patients who developed AKI and subsequent ESRD have
a lower perioperative haemoglobin and higher rates of
transfusion. We have shown previously that pre-
operative anaemia increased the risk of AKI by 23% and
Asians with a smaller body size are particularly vulner-
able to the haemodilution associated with cardiopulmo-
nary bypass and need for subsequent blood transfusion
– a dual insult that exacerbates the hypoxic insult of low
haemoglobin and aggravated by initiation of the systemic
inflammatory response associated with blood transfusion
[1]. There is debate on the optimal haemoglobin to
maintain during cardiopulmonary bypass and it may well
differ between diabetic and non-diabetic patients and
warrants further investigation.
Pre-operative CKD is a major determinant of post-
operative AKI [7]. The transient loss of renal function
(i.e., AKI) in patients with pre-existing CKD can occur
via a few pathways, such as the failure of renal autoregu-
lation, abnormal vasodilatation of the renal vasculature,
increased susceptibility to side effects of anti-
hypertensive agents [20]. However, it is apparent that
even though 29% of our cohort developed AKI, 62.9% of
patients with pre-existing renal impairment had non-re-
covery of acute-on-chronic kidney injury with a steep
downhill trajectory and accelerated ESRD [17, 18].
Continuum of AKI, CKD, ESRD and mortality
Overall, patients who developed ESRD within the
follow-up period have a 5-fold increased risk of mortality
compared with those without ESRD.
It is known that patients who survive an episode of
AKI are at risk for major adverse cardiovascular events
as well as progression to CKD, regardless of whether
there is underlying cardiovascular disease [16]. In this
cardiac surgical population with underlying cardiac
disease, the added insult of AKI and CKD will further
aggravate cardiac disease despite successful revasculari-
zation. Studies suggest that “organ crosstalk” may be ac-
tive long after the initial injury and the acute cardiorenal
injury induces a vicious cycle that persists long after the
acute event [27]. Pre-clinical models demonstrate that
AKI can result in distant organ effects including cardiac
cell apoptosis and cardiac leucocyte infiltration [28–30].
Table 3 Cox regression analysis of perioperative factors and end-stage renal disease and 5-year all-cause mortality
Variables End-stage renal disease 5-year all cause mortality
HR 95% C.I. p-value HR 95% C.I. p-value
Diabetes mellitus 20.6 2.764–153.653 0.003 1.7 1.168–2.438 0.005
Lowest haematocrit during bypass (%) 0.9 0.818–0.991 0.032 0.9 0.901–0.988 0.013
AKIN stage 1 AKI 4.7 1.736–12.603 0.002 1.7 1.165–2.571 0.007
AKIN stage 2–3 AKI 5.8 1.769–18.732 0.004 2.5 1.438–4.229 <0.001
AKIN Acute Kidney Injury Network, C.I. Confidence Interval, HR Hazard Ratio
Fig. 2 Time to mortality for the whole cohort
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Strengths and limitations
This is a prospective study of a cohort of cardiac surgical
patients with clearly defined data points. The patient
population is relatively homogenous with easy access to
healthcare. The present study was protocol driven with
uniform practice among the various anaesthetists, perfu-
sionists and surgeons ensuring reliability of data.
The Singapore Renal Registry is a well-defined nation-
wide cohort with extensive baseline information. The data
capture for ESRD is estimated to be 95% complete [15] as
the National Registry of Diseases Act in 2009 mandates all
physicians to notify, within 3 months from the data of
diagnosis, all ESRD cases to the Singapore Renal Registry
of the National Registry of Diseases Office [31].
One of the limitations is that pre-operative renal
screening was done using serum creatinine which is the
standard of care in Singapore and many parts of the
world. Proteinuria is currently not routinely screened in
patients undergoing cardiac surgery and this would be
part of future prospective studies to enable better renal
risk stratification and counselling.
Also, as AKI was previously believed to be self-limiting,
patients were not routinely followed up at regular intervals
by renal physicians for progression of renal disease.
Conclusions
We have shown that AKI is associated with the long-term
development of ESRD after cardiac surgery. The trajectory
of progression from AKI to CKD and ESRD is rapid
within 5 years after cardiac surgery. ESRD occurs in a
younger age group in our population and leads to signifi-
cant disease burden and high healthcare costs and mortal-
ity. A concerted follow-up assessment by nephrologists
after hospital discharge with periodic assessment of renal
function and urinary protein-creatinine ratio to assess
prognosis and outcome after discharge is advocated for
patients who develop AKI after cardiac surgery.
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